16-55500324-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004530.6(MMP2):​c.1769+1876G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.464 in 151,734 control chromosomes in the GnomAD database, including 16,607 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16607 hom., cov: 31)

Consequence

MMP2
NM_004530.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.369
Variant links:
Genes affected
MMP2 (HGNC:7166): (matrix metallopeptidase 2) This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.605 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MMP2NM_004530.6 linkuse as main transcriptc.1769+1876G>A intron_variant ENST00000219070.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MMP2ENST00000219070.9 linkuse as main transcriptc.1769+1876G>A intron_variant 1 NM_004530.6 P1P08253-1

Frequencies

GnomAD3 genomes
AF:
0.464
AC:
70413
AN:
151616
Hom.:
16605
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.387
Gnomad AMI
AF:
0.348
Gnomad AMR
AF:
0.430
Gnomad ASJ
AF:
0.481
Gnomad EAS
AF:
0.623
Gnomad SAS
AF:
0.505
Gnomad FIN
AF:
0.567
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.489
Gnomad OTH
AF:
0.458
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.464
AC:
70436
AN:
151734
Hom.:
16607
Cov.:
31
AF XY:
0.467
AC XY:
34615
AN XY:
74132
show subpopulations
Gnomad4 AFR
AF:
0.386
Gnomad4 AMR
AF:
0.430
Gnomad4 ASJ
AF:
0.481
Gnomad4 EAS
AF:
0.623
Gnomad4 SAS
AF:
0.507
Gnomad4 FIN
AF:
0.567
Gnomad4 NFE
AF:
0.489
Gnomad4 OTH
AF:
0.454
Alfa
AF:
0.455
Hom.:
7948
Bravo
AF:
0.449
Asia WGS
AF:
0.519
AC:
1808
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.45
DANN
Benign
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs243836; hg19: chr16-55534236; API